Bicara Therapeutics Inc. Common Stock

Stock Chart, Company Information, and Scan Results

$13.89(as of Sep 29, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Bicara Therapeutics Inc. Common Stock Company Information, Fundamentals, and Technical Indicators

Stock Price$13.89
Ticker SymbolBCAX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees55
CountyUSA
Market Cap$638.9M

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Bicara Therapeutics Inc. Common Stock In Our Stock Scanner

As of Sep 30, 2025
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.